Mosanna Therapeutics is a clinical-stage pharmaceutical company developing a nighttime nasal spray therapy for obstructive sleep apnea (OSA). Headquartered in Redwood City, California with an office in Basel, Switzerland, the company is pursuing a pharmacological alternative to mechanical CPAP devices by reactivating the upper-airway muscles that… - View it on GitHub